Welcome to the International Conference and Exhibition on Progressive Medicinal Chemistry (ProMediCon 2027), to be held on April 12β14, 2027, at the HORIBA Symposium Hall, International Science Innovation Building, Kyoto University, Kyoto, Japan.
ProMediCon 2027, co-organized by the Chemical Biology Society of India, will bring together leading researchers, healthcare professionals, industry experts, and young scientists from around the world to share knowledge, discuss emerging trends, and foster collaborations in medicine, healthcare, and life sciences. The conference provides a unique platform to showcase innovative research, exchange ideas, and address global healthcare challenges. Hosted at the prestigious Kyoto University during the beautiful Sakura (Cherry Blossom) season, the conference offers an inspiring environment that combines scientific excellence, cultural heritage, and international networking.
The conference will showcase the latest advancements and emerging trends in the broad field of Medicinal Chemistry. The scientific programme will cover a wide range of key topics, including Drug Discovery and Development, Pharmaceutical Chemistry, Chemical Biology, Bioorganic Chemistry, Computational Drug Design, Molecular Design, Pharmacology, Medicinal Natural Products, ADME and Toxicology, Structure-Based Drug Design, Pharmaceutical Sciences, and Translational Therapeutics. This diverse scope aims to foster interdisciplinary collaboration, encourage the exchange of innovative ideas, and accelerate progress in the development of next-generation therapeutics for global healthcare challenges.
We warmly invite you to join us in Kyoto and contribute to shaping the future of medicine and healthcare through collaboration and innovation.
We look forward to welcoming you to ProMediCon 2027
DSc, FRSC, FNASc, FBRS, FTWAS
NASI Distinguished Chair Professor
Former Vice-Chancellor,
University of Mysore, India
Ambassador, Hokkaido University, Japan
Emeritus Professor
Institute for Integrated Cell-Material Sciences (iCeMS)
Kyoto University, Japan
Director
IN-CBI, WPI-iCeMS
Kyoto University, Japan
Associate Professor
Faculty of Health Sciences and Technology
Hokkaido University, Japan.
PROMEDICON 2027 spans the full spectrum of contemporary medicinal chemistry and pharmaceutical science.
Harnessing AI, quantum computing, and digital twins to transform molecular design at unprecedented scale.
mRNA platforms, antibody-drug conjugates, biologics, and microbiome-based therapeutic innovations.
PROTACs, targeted protein degradation, polypharmacology, and advanced synthesis strategies.
Immuno-oncology, neurodegeneration, rare disease drug discovery, and personalized therapeutics.
Nanomedicine, blood-brain barrier strategies, PK/PD & ADME, and lab-to-market translation.
Radioligand therapy, molecular imaging, and the integration of diagnosis with therapy.
Green and circular chemistry principles, natural products, and eco-friendly pharmaceutical processes.
Autonomous laboratories, high-throughput experimentation, robotics, and AI-driven process optimization.
A comprehensive agenda spanning AI-driven discovery, translational medicine, and sustainable pharmaceutical futures.
FOCUS: AI Β· Data Science Β· Molecular Design Β· Chemical Biology
FOCUS: Biologics Β· Precision Medicine Β· Drug Delivery Β· Theranostics
FOCUS: Green Chemistry Β· Automation Β· Regulation Β· Innovation Ecosystems
PROMEDICON 2027 welcomes the entire drug discovery ecosystem β from bench to boardroom.
Professors, PhD scholars, and computational scientists in medicinal chemistry, chemical biology, and pharmaceutical sciences.
R&D leaders and clinical researchers advancing small molecules, biologics, and next-generation therapeutics.
ML researchers, data scientists, and automation engineers applying machine learning to drug discovery.
Oncologists, neurologists, and clinical investigators driving precision medicine from lab to clinic.
Experts in gene therapy, mRNA platforms, immunotherapy, and targeted protein degradation.
Specialists in sustainable chemistry, catalysis, and scalable pharmaceutical manufacturing.
Specialists in regulatory science, ethics, and global drug approval navigating complex compliance landscapes.
Entrepreneurs, venture capitalists, and innovation leaders driving the next wave of biotech breakthroughs.
MSc and PhD candidates seeking mentorship, collaboration, and career-defining scientific opportunities.
Kyoto, Japan Β· April 12-14, 2027
Secure your place at the premier global gathering of medicinal chemistry and drug discovery innovation. Early-bird rates available for a limited time.